Alternatives for Reducing Chorea in Huntington Disease

Clinical trial NCT01897896 · COMPLETED

Trial details

NCT number: NCT01897896
Sponsor: Auspex Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chorea Associated With Huntington Disease

Start date: 2013-11-12
Primary completion: 2017-08-21
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.